Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global Patterns of Opioid Use and Dependence: Harms to Populations, Interventions, and Future Action Publisher Pubmed



Degenhardt L1 ; Grebely J2 ; Stone J3 ; Hickman M3 ; Vickerman P3 ; Marshall BDL5 ; Bruneau J6, 7 ; Altice FL8 ; Henderson G4 ; Rahimimovaghar A9 ; Larney S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. National Drug and Alcohol Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia
  2. 2. Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia
  3. 3. Population Health Sciences, University of Bristol, Bristol, United Kingdom
  4. 4. Bristol Neuroscience, University of Bristol, Bristol, United Kingdom
  5. 5. School of Public Health, Brown University, Providence, RI, United States
  6. 6. Research Center, Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada
  7. 7. Department of Family and Emergency Medicine, Faculty of Medicine, Universite de Montreal, Succursale Centre-Ville, Montreal, QC, Canada
  8. 8. School of Medicine, Yale University, New Haven, CT, United States
  9. 9. Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran

Source: The Lancet Published:2019


Abstract

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk Factors Study estimated that in 2017, 40·5 million people were dependent on opioids (95% uncertainty interval 34·3–47·9 million) and 109 500 people (105 800–113 600) died from opioid overdose. Opioid agonist treatment (OAT) can be highly effective in reducing illicit opioid use and improving multiple health and social outcomes—eg, by reducing overall mortality and key causes of death, including overdose, suicide, HIV, hepatitis C virus, and other injuries. Mathematical modelling suggests that scaling up the use of OAT and retaining people in treatment, including in prison, could avert a median of 7·7% of deaths in Kentucky, 10·7% in Kiev, and 25·9% in Tehran over 20 years (compared with no OAT), with the greater effects in Tehran and Kiev being due to reductions in HIV mortality, given the higher prevalence of HIV among people who inject drugs in those settings. Other interventions have varied evidence for effectiveness and patient acceptability, and typically affect a narrower set of outcomes than OAT does. Other effective interventions focus on preventing harm related to opioids. Despite strong evidence for the effectiveness of a range of interventions to improve the health and wellbeing of people who are dependent on opioids, coverage is low, even in high-income countries. Treatment quality might be less than desirable, and considerable harm might be caused to individuals, society, and the economy by the criminalisation of extramedical opioid use and dependence. Alternative policy frameworks are recommended that adopt an approach based on human rights and public health, do not make drug use a criminal behaviour, and seek to reduce drug-related harm at the population level. © 2019 Elsevier Ltd
Other Related Docs